Page last updated: 2024-09-02

caffeic acid phenethyl ester and Cancer of Stomach

caffeic acid phenethyl ester has been researched along with Cancer of Stomach in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, N; Endo, S; Ichihara, K; Ikari, A; Matsunaga, T; Tsuchimura, S1
Arı, Z; Kosova, F; Kurt, FO; Olmez, E; Tuğlu, I1

Other Studies

2 other study(ies) available for caffeic acid phenethyl ester and Cancer of Stomach

ArticleYear
Caffeic acid phenethyl ester potentiates gastric cancer cell sensitivity to doxorubicin and cisplatin by decreasing proteasome function.
    Anti-cancer drugs, 2019, Volume: 30, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caffeic Acids; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Phenylethyl Alcohol; Proteasome Endopeptidase Complex; Stomach Neoplasms; Tumor Cells, Cultured

2019
Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2016, Volume: 91, Issue:1

    Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Phenylethyl Alcohol; Stomach Neoplasms

2016